Siemens’ CFO, Ralf Thomas, announced that the company is reevaluating its majority stake in medical technology subsidiary Siemens Healthineers. Thomas stated that the synergy between the two companies doesn’t justify the €45 billion capital commitment. Siemens is exploring economic opportunities in healthcare to determine the investment’s role, with conclusions expected by the end of 2025. This follows a recent statement that Siemens might sell about 5% of Healthineers to fund the acquisition of US software company Altair. Separately, Thomas reaffirmed Siemens’ commitment to its Mobility train division, citing its strategic value to the company, despite calls from investors for divestiture. The Mobility division was acquired by Siemens through its merger with Alstom in 2019. Thomas’ comments on Healthineers and Mobility were made during the company’s Capital Markets Day presentation.
Siemens Acquires Majority Control of Siemens Healthineers
by newsworm | Dec 30, 2024 | Siemens | 0 comments